Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Alpharma, Inc. | Pfizer | pharmaceuticals | price-fixing or anti-competitive practices | 2004 | MULTI-AG | $750,000 |
Amgen and Immunex | Amgen | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $3,500,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IL-AG | $7,200,000 |
Amgen Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2008 | WI-AG | $2,000,000 |
Amgen Inc. | Amgen | pharmaceuticals | off-label or unapproved promotion of medical products | 2015 | MULTI-AG | $71,000,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2013 | MULTI-AG | $11,000,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
Amneal Pharmaceuticals, LLC | Amneal Pharmaceuticals | pharmaceuticals | Medicare Coverage Gap Discount Program violation | 2019 | CMS | $12,968 |
Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |
Anda | Teva Pharmaceutical Industries | pharmaceuticals | Controlled Substances Act violation | 2016 | WV-AG | $1,800,000 |
Apotex | Apotex Corp. | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Astellas | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2004 | FL-AG | $807,826 |
AstraZeneca | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | consumer protection violation | 2010 | KY-AG | $5,391,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $46,500,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2003 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $24,900,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,600,000 |
AstraZeneca Pharmaceuticals LP | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993 |
AstraZeneca Pharmaceuticals LP and AstraZeneca LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2011 | ID-AG | $2,500,000 |
AstraZeneca Pharmaceuticals, LP | AstraZeneca | pharmaceuticals | False Claims Act and related | 2010 | HI-AG | $3,333,333 |
Aventis | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Aventis Pharmaceutical Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $40,000,000 |
Aventis Pharmaceutical L.P. | Sanofi | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2007 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $10,645,600 |
Aventis Pharmaceuticals Inc. | Sanofi | pharmaceuticals | False Claims Act and related | 2010 | NJ-AG | $1,300,000 |
Aventis Pharmaceuticals, Inc. | Sanofi | pharmaceuticals | price-fixing or anti-competitive practices | 2012 | MULTI-AG | $1,650,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Barr Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $5,900,000 |
Bausch & Lomb | Bausch Health | pharmaceuticals | price-fixing or anti-competitive practices | 2001 | MULTI-AG | $17,500,000 |
Biogen Idec Inc. | Biogen | pharmaceuticals | consumer protection violation | 2007 | VT-AG | $10,000 |
Biovail | Bausch Health | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $200,000 |
Boehringer Ingelheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Boehringer Ingelheim Corp. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2005 | TX-AG | $10,000,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | $13,500,000 |
Boehringer Ingelheim Pharmaceuticals, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $7,750,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Boehringer Ingelheim Roxane, Inc. et al. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $357,000 |
Boehringer Ingleheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2011 | KS-AG | $1,400,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2016 | MULTI-AG | $19,500,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2003 | MULTI-AG | $55,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $11,000,000 |
Bristol-Myers Squibb | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2010 | PA-AG | $27,600,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | price-fixing or anti-competitive practices | 2008 | MULTI-AG | $1,100,000 |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | pharmaceuticals | consumer protection violation | 2019 | WV-AG | $1,600,000 |
Bristol-Myers Squibb Company and Apothecon, Inc. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2008 | ID-AG | $1,738,719 |
Celgene Corp. | Bristol-Myers Squibb | pharmaceuticals | off-label or unapproved promotion of medical products | 2017 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000 |
Cephalon | Teva Pharmaceutical Industries | pharmaceuticals | consumer protection violation | 2016 | MULTI-AG | $125,000,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | CT-AG | $6,150,000 |
Cephalon, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $7,500,000 |
CIBA Vision | Novartis | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $5,000,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $4,340,100 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $1,446,700 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Dava Pharmaceuticals, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2012 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $11,000,000 |
DePuy Orthopaedics Inc. | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2014 | OR-AG | $4,000,000 |
Dey | Viatris | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2005 | CT-AG | $2,500,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | OH-AG | $4,000,000 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2004 | WV-AG | $850,000 |
Dey L.P. | Viatris | pharmaceuticals | False Claims Act and related | 2008 | AL-AG | $4,750,000 |
Dey Labs | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Dey LP | Viatris | pharmaceuticals | False Claims Act and related | 2007 | MT-AG | $198,000 |
Dey Pharmaceuticals | Viatris | pharmaceuticals | False Claims Act and related | 2011 | PA-AG | $2,000,000 |
Dey, Inc. | Viatris | pharmaceuticals | fraud | 2004 | AR-AG | $600,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | HI-AG | $1,150,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2009 | IA-AG | $1,800,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | ID-AG | $1,072,700 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | NV-AG | $670,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2003 | TX-AG | $9,000,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | WI-AG | $2,000,000 |
Eisai | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $7,634,700 |
Eisai | Eisai | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | CA-AG | $2,544,900 |
Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | AR-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
Eli Lilly & Co. | Eli Lilly | pharmaceuticals | privacy violation | 2002 | MULTI-AG | $160,000 |
Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | CT-AG | $25,100,000 |
Eli Lilly and Co. | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | ID-AG | $13,000,000 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456 |
Eli Lilly and Company | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2008 | MULTI-AG | $62,000,000 |
Endo Health Solution | Endo International | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $173,000,000 |
Endo Health Solutions | Endo International | pharmaceuticals | False Claims Act and related | 2015 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $39,000,000 |
Endo Health Solutions Inc. and Endo Pharmaceuticals Inc. | Endo International | pharmaceuticals | drug or medical equipment safety violation | 2016 | NY-AG | $200,000 |
Endo International plc | Endo International | pharmaceuticals | price-fixing or anti-competitive practices | 2019 | MULTI-AG | $2,300,000 |
Endo Pharmaceuticals | Endo International | pharmaceuticals | consumer protection violation | 2019 | CA-AG | $760,000 |
Endo Pharmaceuticals | Endo International | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $18,170,000 |
Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2009 | AL-AG | $14,833,333 |
Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | TX-AG | $3,000,000 |